Literature DB >> 25957531

Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters.

Wanrudee Isaranuwatchai1,2, Maureen Markle-Reid3, Jeffrey S Hoch4,5.   

Abstract

BACKGROUND AND
OBJECTIVE: The literature has shown that different baseline adjustment approaches lead to different results when examining cost and quality-adjusted life-years. To our knowledge, the concept of baseline adjustment in a net benefit (NB) regression has not been studied. The purpose of the study was to explore the impact of different baseline adjustment approaches in an NB framework on the cost effectiveness of an intervention using person-level data.
METHODS: This study used data from a randomized controlled trial that evaluated the effectiveness of a multifactorial falls prevention intervention for older home care clients. The outcome was the number of falls at the 6-month follow-up. The cost variable was the total healthcare costs from a societal perspective. Incremental NB values were estimated using four baseline adjustment approaches: (1) the change in NB is the dependent variable; (2) the NB at follow-up is the dependent variable without adjusting for baseline values; (3) the NB at follow-up is the dependent variable adjusting for baseline NB; and (4) the NB at follow-up is also the dependent variable adjusting for baseline cost and effect separately.
RESULTS: With adjustment of baseline values (Approach 1, 3, 4), the intervention was not cost effective when compared to usual care. Conversely, without baseline adjustment (Approach 2), the intervention was cost effective if decision-makers' willingness-to-pay per fall prevented was CAN$10,000 or greater.
CONCLUSIONS: This study showed that different baseline adjustment approaches in a cost-effectiveness analysis can lead to different results. Future research is needed to determine the most appropriate adjustment approach in planning economic evaluation using NB regression.

Entities:  

Mesh:

Year:  2015        PMID: 25957531     DOI: 10.1007/s40273-015-0287-6

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  18 in total

Review 1.  Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Authors:  A J Vickers; D G Altman
Journal:  BMJ       Date:  2001-11-10

2.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

Authors:  Andrea Manca; Neil Hawkins; Mark J Sculpher
Journal:  Health Econ       Date:  2005-05       Impact factor: 3.046

Review 3.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

4.  Comparing the cost-effectiveness of simulation modalities: a case study of peripheral intravenous catheterization training.

Authors:  Wanrudee Isaranuwatchai; Ryan Brydges; Heather Carnahan; David Backstein; Adam Dubrowski
Journal:  Adv Health Sci Educ Theory Pract       Date:  2013-06-01       Impact factor: 3.853

5.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

7.  Designs for experiments--parallel comparisons of treatment.

Authors:  P W Lavori; T A Louis; J C Bailar; M Polansky
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

Review 8.  Interventions for preventing falls in older people living in the community.

Authors:  Lesley D Gillespie; M Clare Robertson; William J Gillespie; Sarah E Lamb; Simon Gates; Robert G Cumming; Brian H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  How to deal with cost differences at baseline.

Authors:  Antoinette D I van Asselt; Ghislaine A P G van Mastrigt; Carmen D Dirksen; Arnoud Arntz; Johan L Severens; Alfons G H Kessels
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.

Authors:  Jeffrey S Hoch; Marie Antoinette Rockx; Andrew D Krahn
Journal:  BMC Health Serv Res       Date:  2006-06-06       Impact factor: 2.655

View more
  5 in total

1.  Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer.

Authors:  Wei Fang Dai; Jaclyn M Beca; Chenthila Nagamuthu; Ning Liu; Claire de Oliveira; Craig C Earle; Maureen Trudeau; Kelvin K W Chan
Journal:  JAMA Oncol       Date:  2022-04-01       Impact factor: 31.777

2.  The statistical approach in trial-based economic evaluations matters: get your statistics together!

Authors:  Elizabeth N Mutubuki; Mohamed El Alili; Judith E Bosmans; Teddy Oosterhuis; Frank J Snoek; Raymond W J G Ostelo; Maurits W van Tulder; Johanna M van Dongen
Journal:  BMC Health Serv Res       Date:  2021-05-19       Impact factor: 2.655

3.  Self-wise, Other-wise, Streetwise (SOS) training: a novel intervention to reduce victimization in dual diagnosis psychiatric patients with substance use disorders: protocol for a randomized controlled trial.

Authors:  Marleen M de Waal; Martijn J Kikkert; Matthijs Blankers; Jack J M Dekker; Anna E Goudriaan
Journal:  BMC Psychiatry       Date:  2015-10-29       Impact factor: 3.630

4.  Efficacy of an internet-based self-help intervention to reduce co-occurring alcohol misuse and depression symptoms in adults: study protocol of a three-arm randomised controlled trial.

Authors:  Michael P Schaub; Matthijs Blankers; Dirk Lehr; Leif Boss; Heleen Riper; Jack Dekker; Anna E Goudriaan; Larissa J Maier; Severin Haug; Manuel Amann; Michelle Dey; Andreas Wenger; David D Ebert
Journal:  BMJ Open       Date:  2016-05-25       Impact factor: 2.692

5.  Prevention of violent revictimization in depressed patients with an add-on internet-based emotion regulation training (iERT): study protocol for a multicenter randomized controlled trial.

Authors:  Carolien Christ; Marleen M de Waal; Digna J F van Schaik; Martijn J Kikkert; Matthijs Blankers; Claudi L H Bockting; Aartjan T F Beekman; Jack J M Dekker
Journal:  BMC Psychiatry       Date:  2018-02-02       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.